300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Middle East
Indonesia
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology VC Funds & Investors in Finland (September 2026)

The most active venture capital funds investing in Finland Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Finland Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Tesi
VC Fund
12 Finland, United States, Switzerland Series A, Series B Software, Manufacturing, Health Care $2.4M–$46M
Business Finland
VC Fund
12 Finland, United States, Sweden Grant, Seed, Debt Financing Software, SaaS, Biotechnology $50k–$10M
Lifeline Ventures
VC Fund
10 Finland, United States, United Kingdom Seed, Series A, Venture - Series Unknown Software, Health Care, Artificial Intelligence $580k–$22M
Voima Ventures
VC Fund
9 Finland, Sweden, Norway Seed, Pre-Seed, Series A Biotechnology, Health Care, Artificial Intelligence $464k–$30M
Finnvera Venture Capital
VC Fund
8 Finland, United States, Chile Seed, Series A Software, Health Care, Manufacturing $250k–$23M
Springvest
VC Fund
8 Finland Series A, Venture - Series Unknown, Seed Biotechnology, Health Care, Medical $1.6M–$53M
Butterfly Ventures
VC Fund
7 Finland, Sweden, Norway Seed, Pre-Seed Software, Health Care, Information Technology $110k–$4.3M
Inventure
VC Fund
4 Finland, Sweden, United States Seed, Series A, Series B Software, Information Technology, Health Care $549k–$25M
European Investment Bank
VC Fund
4 France, Germany, The Netherlands Debt Financing, Post-IPO Debt Biotechnology, Health Care, Energy $16M–$587M
VTT Ventures
VC Fund
4 Finland Seed, Venture - Series Unknown, Series A Manufacturing, Biotechnology, Electronics $460k–$14M
Maki.vc
VC Fund
4 Finland, Norway, Denmark Seed, Series A, Pre-Seed Software, E-Commerce, Information Technology $578k–$37M
Nordic Science Investments
VC Fund
4 Finland, Sweden, United States Seed, Pre-Seed, Series A Biotechnology, Medical, Health Diagnostics $373k–$4.6M
Innovestor
VC Fund
4 Finland, Sweden, Denmark Seed, Venture - Series Unknown, Pre-Seed Software, Health Care, Information Technology $204k–$5.8M
Icebreaker.vc
VC Fund
4 Finland, Sweden, Estonia Pre-Seed, Seed, Series A Software, Information Technology, Artificial Intelligence $110k–$25M
Stephen Industries
VC Fund
3 Finland, Sweden Seed, Series A, Pre-Seed Software, Health Care, Biotechnology $330k–$45M
Agronomics
VC Fund
3 United States, Finland, Germany Series A, Seed, Series B Biotechnology, Food and Beverage, Food Processing $894k–$55M
Nordic Foodtech VC
VC Fund
3 Finland, Denmark, Sweden Seed, Pre-Seed, Series A Biotechnology, Food and Beverage, Life Science $610k–$18M
Sitra
VC Fund
2 Finland, The Netherlands Grant, Series A Health Care, Biotechnology, CleanTech
HealthCap
VC Fund
2 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $6M–$92M
Fazer
VC Fund
2 Finland Series A, Series B, Venture - Series Unknown Energy, Biotechnology, Food Processing
Thames Trust
VC Fund
2 United Kingdom, Finland Series A, Seed, Series B Software, SaaS, Music $5M–$15M
Pontos Group
VC Fund
2 Finland, Estonia Venture - Series Unknown, Seed Apps, Mobile, Content $6.3M–$16M
Finnish Climate Fund
VC Fund
2 Finland Debt Financing, Venture - Series Unknown, Series A Energy, Renewable Energy, Sustainability $2.5M–$12M
Creathor Ventures
VC Fund
2 Germany, Switzerland, United States Series A, Series B Software, Health Care, Biotechnology $2M–$30M
NordicNinja VC
VC Fund
2 Sweden, Finland, Estonia Series A, Series B, Seed Software, Information Technology, Artificial Intelligence $1.9M–$62M
Valve Ventures
VC Fund
2 Finland Seed, Series A, Venture - Series Unknown Energy, CleanTech, Construction $560k–$30M
ACME Investments
VC Fund
2 Finland Series A, Venture - Series Unknown Health Care, Biotechnology, Apps
StartUp Health
VC Fund
2 United States, Canada, United Kingdom Seed, Pre-Seed Health Care, Wellness, Medical $20k–$4M
Sto-Rahoitus
VC Fund
2 Finland Series A Biotechnology, Medical, Software $2M–$5.9M
Sofinnova Partners
VC Fund
2 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
EQT Life Sciences
VC Fund
2 United States, The Netherlands, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7.3M–$165M
Lundbeckfonden Ventures
VC Fund
1 United States, Denmark, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $10M–$95M
K5 Global
VC Fund
1 United States, United Kingdom, Brazil Seed, Series A, Pre-Seed Software, Information Technology, Artificial Intelligence $50k–$41M
Tiger Global Management
VC Fund
1 United States, India, China Series B, Series A, Series C Software, FinTech, Financial Services $6.5M–$255M
CPT Capital
VC Fund
1 United States, Israel, United Kingdom Seed, Series A, Series B Food and Beverage, Biotechnology, Food Processing $1.3M–$226M
Keksintösäätiö
VC Fund
1 Finland Seed Apps, Health Care, Biotechnology
Horizon 2020
VC Fund
1 Spain, United Kingdom, Switzerland Grant, Seed, Venture - Series Unknown Health Care, Biotechnology, Medical $56k–$9.2M
Metsola Ventures
VC Fund
1 Finland Series A, Pre-Seed Medical, mHealth, Automotive $2.2M–$5.4M
Advent Life Sciences
VC Fund
1 United States, United Kingdom, France Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $5.5M–$104M
Green Campus Innovations Oy
VC Fund
1 Finland, Norway Pre-Seed, Venture - Series Unknown, Seed Energy, Manufacturing, Electric Vehicle $616k–$2.5M
MTIP AG
VC Fund
1 United States, United Kingdom, Spain Series A, Series B, Series C Health Care, Medical, Artificial Intelligence $1.5M–$80M
Capricorn Partners
VC Fund
1 Belgium, The Netherlands, United States Series A, Series B Biotechnology, Health Care, Software $3.3M–$45M
Bridford Investments
VC Fund
1 Sweden, Belgium, Finland Venture - Series Unknown, Series A, Series B Biotechnology, Manufacturing, Energy $6.1M–$2.8B
Novartis Venture Fund
VC Fund
1 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$120M
XR Invest
VC Fund
1 Finland, United States Series A, Series B, Series C Medical Device, Sensor, Medical
Wave Ventures
VC Fund
1 Finland, Sweden, Germany Seed, Pre-Seed Software, Mobile Apps, Information Technology
Zhejiang Huahai Pharmaceutical
VC Fund
1 China, Finland Series A Biotechnology, Pharmaceutical, Therapeutics
Nordea
VC Fund
1 Finland, Sweden, Norway Debt Financing, Seed FinTech, Financial Services, Banking
University of Helsinki
VC Fund
1 Finland, Luxembourg Seed, Grant, Pre-Seed Apps, Hospital, Consulting
Valio
VC Fund
1 Finland Series A, Series B Life Science, Biotechnology
Access all 157 VC funds in Finland Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Tesi
VC Fund · Helsinki, Southern Finland, Finland · 12 investments in Finland Biotechnology startups

Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570

Show more...

Investment focus

  • Industry: Software, Manufacturing, Health Care
  • Stage:Series A, Series B
  • Geography: Finland, United States, Switzerland

Investor stats

  • Total investments: 152
  • Round size: Series A $2.4M–$46M; Series B $3.1M–$37M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $177M in 2017

Portfolio highlights

  • ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
  • Vexlum — A #laser company providing high-power #VECSELs for #QuantumTechnology
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Show all investments...

Business Finland
VC Fund · Helsinki, Southern Finland, Finland · 12 investments in Finland Biotechnology startups, 17 in the past 12 months

Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.

Show more...

Investment focus

  • Industry: Software, SaaS, Biotechnology
  • Stage:Grant, Seed, Debt Financing
  • Geography: Finland, United States, Sweden

Investor stats

  • Total investments: 235
  • Round size: Seed $334k–$3.5M; Grant $50k–$10M; Debt Financing $241k–$6.5M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • STRGY AI — The strategy was never the problem. The evidence was correct, sitting in someone's hands, and it died anyway because nothing in the organization was built to carry that evidence from where it was seen to where it could be acted on, and keep it alive long enough to matter. Not a bad plan. Not bad people. A structural gap between signal andauthority that every existing tool — decks, dashboards, status meetings — is too static and too easy to ignore to actually close.STRGY exists because that gap is the default state of every organization above a certain size, and closing it has always required either a heroic individual repeating themselves for years or luck (the corporate pilot needed one person to remember "do not drop this" at the right moment, and no one did). That's not a strategy problem to solve with a better framework — it's an infrastructure problem. You need something that holds the signal, doesn't forget it, doesn't get bored repeating it, and resurfaces it automatically the moment the gap between evidence and action starts to widen. That's what a human can't do reliably at scale, and what software with real memory can.
  • Coolbrook — Our RotoDynamic electric technology can cut 30% of industrial emissions annually, delivering hope at industrial scale.
  • Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
Show all investments...

Lifeline Ventures
VC Fund · Helsinki, Southern Finland, Finland · 10 investments in Finland Biotechnology startups

Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Finland, United States, United Kingdom

Investor stats

  • Total investments: 201
  • Round size: Seed $580k–$5.4M; Series A $2.8M–$22M; Venture - Series Unknown $616k–$17M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely actively investing — fresh fund, raised $464M in 2025

Portfolio highlights

  • S-Transistors — S-Transistors is one of the few businesses founded on a truly novel core technology that has the potential to serve as an enabling layer for a whole industry.
  • Thor Dynamics — Directed Energy Systems for Counter-Drone Defense
  • Everywear Games — Everywear Games is the world’s leading wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s gamesare consistently on top of global charts.
Show all investments...

Voima Ventures
VC Fund · Helsinki, Southern Finland, Finland · 9 investments in Finland Biotechnology startups, 6 in the past 12 months

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 61
  • Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
  • Lead/follow: 64% lead, 36% follow
  • Last fund: Likely still investing — raised $108M in 2023

Portfolio highlights

  • Reduciner — Reduciner's vision to turn industrial CO₂ emissions from a liability into a valuable resource. Its technology converts captured carbon dioxide and biochar into valuable feedstocks such as carbon monoxide and activated carbon, enabling circular carbon use in emissions-intensive industries. Reduciner combines strong scientific expertise withindustrial applicability across sectors such as cement, steel, and chemicals. Its electricity-driven process allows industries to reduce emissions without major changes to existing infrastructure, offering a resilient and cost-competitive way to reduce carbon dependency while creating new value from CO₂ emissions.
  • TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
  • Photoncycle — The year-round solar energy system for heating and electricity
Show all investments...

Finnvera Venture Capital
VC Fund · Kuopio, Eastern Finland, Finland · 8 investments in Finland Biotechnology startups

Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: Finland, United States, Chile

Investor stats

  • Total investments: 95
  • Round size: Seed $250k–$2.3M; Series A $1.8M–$23M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
  • eMabler — EMabler is an EV charging infrastructure software company that develops an API-first platform used by businesses to operate, manage, and scale electric vehicle charging networks. It provides a centralized system for charge point management, billing, pricing, roaming, and energy optimization, allowing operators to control large networks of EVchargers from a single platform. The software connects charging hardware with business systems such as CRM, payment, and energy management tools through open APIs and a large library of integrations. The company focuses on enabling enterprises, such as energy utilities, parking operators, and retail businesses, to embed EV charging directly into their existing services and digital platforms rather than building standalone charging systems. This includes white-label solutions where charging is integrated into a company’s own app or customer experience under its brand.
  • CHAOS — At CHAOS, we strive to democratize data and harness the power of AI and cutting-edge technology, delivering transformative location insights that empower decision-makers to design more liveable cities- sustainable, human-centered where the quality-of-life soars.
Show all investments...

Springvest
VC Fund · Helsinki, Southern Finland, Finland · 8 investments in Finland Biotechnology startups

The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Venture - Series Unknown, Seed
  • Geography: Finland

Investor stats

  • Total investments: 23
  • Round size: Seed $1.6M–$7.6M; Series A $3.6M–$53M; Venture - Series Unknown $4.7M–$29M
  • Lead/follow: 74% lead, 26% follow

Portfolio highlights

  • ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
  • MedicubeX — MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location.
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Show all investments...

Butterfly Ventures
VC Fund · Oulu, Oulu, Finland · 7 investments in Finland Biotechnology startups

Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 91
  • Round size: Seed $224k–$2.1M; Pre-Seed $110k–$4.3M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $49M in 2022

Portfolio highlights

  • DREV — DREV is a cleantech company manufacturing contamination control solutions for the world’s most advanced manufacturing facilities.
  • Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
  • Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Show all investments...

Inventure
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Finland Biotechnology startups

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 179
  • Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $140M in 2022

Portfolio highlights

  • Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
  • Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
  • Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 4 investments in Finland Biotechnology startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Energy
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, Germany, The Netherlands

Investor stats

  • Total investments: 586
  • Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$370M
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
  • Skyborn Renewables — Skyborn Renewables develops, builds, and operates offshore wind projects across the full lifecycle. The company identifies sites, secures permits, structures financing, and manages engineering, procurement, and construction. Its teams plan grid connections and deliver operations and maintenance for utility-scale assets. Skyborn Renewables alsoprovides asset management, health and safety oversight, and environmental monitoring throughout project life. Services include offtake strategy and power sales support, stakeholder engagement, and supply chain coordination. The portfolio covers greenfield development, joint ventures, and acquisitions, with capabilities from early-stage studies to long-term operation. Technology work spans turbine selection, foundation design, cable layout, and digital performance analytics. Skyborn Renewables collaborates with partners to expand renewable generation and enable electrification through offshore wind energy.
Show all investments...

VTT Ventures
VC Fund · Espoo, Southern Finland, Finland · 4 investments in Finland Biotechnology startups

VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Electronics
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Finland

Investor stats

  • Total investments: 24
  • Round size: Seed $460k–$3.3M; Series A $1.8M–$14M; Venture - Series Unknown $1.5M–$9.2M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
  • Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
  • Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Maki.vc
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Finland Biotechnology startups, 6 in the past 12 months

We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention.We invest in early stage companies: fromtheir inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Finland, Norway, Denmark

Investor stats

  • Total investments: 103
  • Round size: Seed $948k–$8.3M; Pre-Seed $578k–$2.7M; Series A $3.5M–$37M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $106M in 2024

Portfolio highlights

  • Aavuus — Aavuus is building a global network of ground-based laser stations to detect and track space debris with high precision.
  • Metaktik — Tactical Metasurface Antenna Solution for Defence. Ultralight Antennas for Satellites.
  • Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
Show all investments...

Nordic Science Investments
VC Fund · 4 investments in Finland Biotechnology startups

We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Diagnostics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 17
  • Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
  • Lead/follow: 88% lead, 12% follow
  • Last fund: Likely still investing — raised $34M in 2024

Portfolio highlights

  • CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
  • mu-ray.tech — MuRay Tech generates a controlled muon beam to image inside solid metal and 3D printed pieces. Non-destructively. In minutes.
  • Perfat Technologies — Perfect fats for better foods.
Show all investments...

Innovestor
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Finland Biotechnology startups

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Finland, Sweden, Denmark

Investor stats

  • Total investments: 93
  • Round size: Seed $477k–$4.5M; Pre-Seed $204k–$2M; Venture - Series Unknown $529k–$5.8M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: Likely still investing — raised $33M in 2023

Portfolio highlights

  • STRGY AI — The strategy was never the problem. The evidence was correct, sitting in someone's hands, and it died anyway because nothing in the organization was built to carry that evidence from where it was seen to where it could be acted on, and keep it alive long enough to matter. Not a bad plan. Not bad people. A structural gap between signal andauthority that every existing tool — decks, dashboards, status meetings — is too static and too easy to ignore to actually close.STRGY exists because that gap is the default state of every organization above a certain size, and closing it has always required either a heroic individual repeating themselves for years or luck (the corporate pilot needed one person to remember "do not drop this" at the right moment, and no one did). That's not a strategy problem to solve with a better framework — it's an infrastructure problem. You need something that holds the signal, doesn't forget it, doesn't get bored repeating it, and resurfaces it automatically the moment the gap between evidence and action starts to widen. That's what a human can't do reliably at scale, and what software with real memory can.
  • Amplifiles — Amplifiles is a PropTech startup that turns real estate listing photos into fully branded, high-quality videos in minute, no filming or editing required. Our video engine helps agents, photographers, and marketplaces boost engagement, generate more leads, and unlock new revenue streams.
  • Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Show all investments...

Icebreaker.vc
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Finland Biotechnology startups

Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Finland, Sweden, Estonia

Investor stats

  • Total investments: 143
  • Round size: Seed $409k–$5.4M; Pre-Seed $110k–$1.3M; Series A $3.1M–$25M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — raised $24M in 2021

Portfolio highlights

  • Cytely — Cytely operationalizes biological measurement, turning microscopy into standardized, reproducible data so research teams can accelerate discovery.
  • Oplane — Connect your repo. See and fix your vulnerabilities in minutes. AI-powered threat modeling - no consultants, no weeks of docs.
  • Cota Robotics — Cota Robotics deploys general-purpose robots in retail stores through a Robot-as-a-Service model, integrating with existing environments without requiring changes to store layouts or infrastructure. The company automates shelf replenishment, inbound handling, and order picking using human-in-the-loop teleoperation, with autonomy increasing asdeployment data trains its models.
Show all investments...

Stephen Industries
VC Fund · Espoo, Southern Finland, Finland · 3 investments in Finland Biotechnology startups

We fund futurebreakthroughs

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Finland, Sweden

Investor stats

  • Total investments: 18
  • Round size: Seed $482k–$8.2M; Pre-Seed $330k–$4.3M; Series A $8.3M–$45M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • AlixLabs — AlixLabs is a Swedish semiconductor startup, founded in 2019.
  • Anferra — Turning hazardous steel waste into clean water and green energy.
  • Freepress.ai — Freepress curates verified and diverse global perspectives on current news into bite-sized news stories in your language.
Show all investments...

Agronomics
VC Fund · Douglas, South Lanarkshire, United Kingdom · 3 investments in Finland Biotechnology startups

Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Series A, Seed, Series B
  • Geography: United States, Finland, Germany

Investor stats

  • Total investments: 48
  • Round size: Seed $894k–$11M; Series A $6M–$47M; Series B $2.4M–$55M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Meatable — Meatable is a food production company that produces guilt-free meat. Meatable is a company that creates manufactured meat using stem cell technology. By employing pluripotent stem cells, which have the potential to transform any type of cell from muscle to fat without serum, the company's method eliminates the need to remove any tissue from ananimal, allowing consumers to have sustainable food.
  • SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
  • Meatly — Good Dog Food creates cultivated meat for healthy pets and a healthy planet
Show all investments...

Nordic Foodtech VC
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Finland Biotechnology startups

We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Life Science
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Denmark, Sweden

Investor stats

  • Total investments: 31
  • Round size: Seed $610k–$5.3M; Pre-Seed $880k–$1.9M; Series A $6.8M–$18M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: Likely actively investing — fresh fund, raised $42M in 2024

Portfolio highlights

  • Fiberdom — Fiberdom develops sustainable materials from wood fibers, focusing on plastic-free solutions. The company offers a range of compostable cutlery designed for food service and take-away applications. These products are fully recyclable and comply with European regulations, making them suitable for environmentally conscious consumers. Fiberdomemphasizes innovation in transforming wood fibers into high-performance materials, contributing to sustainability efforts in various industries. The commitment to creating eco-friendly alternatives positions Fiberdom as a key player in the materials innovation sector.
  • MÖ Foods — MÖ Kaurajogu is domestic, completely herbal and above all delicious. All our products are manufactured in Central Ostrobothnia, Lohtaja.
  • AquaNab Solutions — AquaNab is a biotechnology startup developing precision immunotherapies for aquaculture. The company's core platform uses alpaca-derived nanoantibodies (called AquaNabs) formulated directly into fish feed. This approach allows the therapeutic molecules to cross the fish's intestinal barrier and target pathogens from the bloodstream.
Show all investments...

Sitra
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, CleanTech
  • Stage:Grant, Series A
  • Geography: Finland, The Netherlands

Investor stats

  • Total investments: 8
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • Headai — We help organizations succeed in a rapidly changing future by helping them find answers in large amounts of data that they can't otherwise see. Our algorithms help customers see the big picture in scattered data by revealing unknown connections and even explaining why they exist. 100% own IP, combines the strengths of Natural LanguageProcessing, self-organized learning, reinforcement learning and 20+ years experience on cognitive sciences.
  • SET Ventures — SET propels founders from early growth to European scale. We invest in and grow the solutions powering the digital energy economy.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Finland Biotechnology startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 141
  • Round size: Series A $6M–$73M; Series B $12M–$92M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $179M in 2024

Portfolio highlights

  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Fazer
VC Fund · Vantaa, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

Fazer Group mission is to create taste sensations. Customer orientation, quality and operations are based.

Show more...

Investment focus

  • Industry: Energy, Biotechnology, Food Processing
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Finland

Investor stats

  • Total investments: 3
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Thames Trust
VC Fund · London, England, United Kingdom · 2 investments in Finland Biotechnology startups

Thames Trust

Show more...

Investment focus

  • Industry: Software, SaaS, Music
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, Finland

Investor stats

  • Total investments: 5
  • Round size: Series A $5M–$15M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • STEM — For makers, learners, and players. Creative computing projects, stories, and more.
  • Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
  • ABAKA Holdings — ABAKA is world's first digital saving and retirement enterprise SaaS platform, powered by Artificial Intelligence. Our innovative technologies enable financial institutions to power digital saving and retirement solutions and deliver scalable and affordable advice on pensions, savings and investments to their retail customers. ABAKA’s libraryof modular applications helps our enterprise clients to power conversational AI, personalised and behavioural nudges, big data insights, financial dashboards and outstanding customer experiences.Today over 9 million people have access to the ABAKA technologies through our clients, and our technologies are licensed by Tier one international banks, pension providers and asset managers across multiple countries.ABAKA’s enterprise solutions enable financial institutions to power: • Conversational AI: on pensions, savings and investments, for both fully digital and hybrid advice. The proprietary NLP models take vast quantities of user behavioural and financial data to intelligently manage a human like conversation. • Intelligent Behavioural Nudges: machine learning models to identify persona segmentation, power personalised insights and nudges to increase engagement and up-sell opportunities, across digital channels. • Digital financial dashboards: data aggregation technology powering Open Banking, Pension Tracing and Pension Dashboards. • Financial Planning Engine: retirement planning, cash flow modelling, suitability assessment, Monte-Carlo simulations for outcome & scenario driven advice
Show all investments...

Pontos Group
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.

Show more...

Investment focus

  • Industry: Apps, Mobile, Content
  • Stage:Venture - Series Unknown, Seed
  • Geography: Finland, Estonia

Investor stats

  • Total investments: 5
  • Round size: Venture - Series Unknown $6.3M–$16M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Hintsa — Discover a better you, with methods proven in Formula 1 and Fortune 500.
  • R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
  • Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Show all investments...

Finnish Climate Fund
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

The Climate Fund focuses on combating climate change, boosting low-carbon industry and promoting digitalisation.

Show more...

Investment focus

  • Industry: Energy, Renewable Energy, Sustainability
  • Stage:Debt Financing, Venture - Series Unknown, Series A
  • Geography: Finland

Investor stats

  • Total investments: 21
  • Round size: Debt Financing $2.5M–$12M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
  • Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
  • Volare — Refining food, beverage and agricultural sidestreams into protein, oil and fertilizers. Sustainable Black Soldier Fly Protein & Oil for Pet Food and Aquafeed from Finland.
Show all investments...

Creathor Ventures
VC Fund · Bad Homburg, Hessen, Germany · 2 investments in Finland Biotechnology startups

We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 96
  • Round size: Series A $2M–$12M; Series B $5.1M–$30M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $90M in 2016

Portfolio highlights

  • SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
  • CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
  • Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
Show all investments...

NordicNinja VC
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

NordicNinja VC invests in startups in the Nordic-Baltic region.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: Sweden, Finland, Estonia

Investor stats

  • Total investments: 56
  • Round size: Seed $1.9M–$12M; Series A $5M–$30M; Series B $15M–$62M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • LiveEO — LiveEO is the leading solution provider for AI-powered satellite-based monitoring of large infrastructure networks. Trusted worldwide.
  • RedpineAI — Redpine powers AI builders and autonomous agents with access to licensed, high-quality and multimodal data - securely and at scale.
  • CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
Show all investments...

Valve Ventures
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

Valve Ventures is a Helsinki-based angel and early-stage venture investor.

Show more...

Investment focus

  • Industry: Energy, CleanTech, Construction
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Finland

Investor stats

  • Total investments: 15
  • Round size: Seed $560k–$3.2M; Series A $2.5M–$30M; Venture - Series Unknown $1.1M–$4.1M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
  • QHeat — QHeat offers Clean geothermal energy solutions for sustainable built environments
  • Betolar — Betolar is a materials technology company that develops circular economy solutions for the mining, metals, and construction sectors by transforming industrial sidestreams and waste materials into valuable products. Its technologies support the production of low-carbon, cement-free construction materials and enable the recovery of critical andstrategic metals from industrial waste streams. The company provides material analysis, consulting, and recipe optimization services, utilizing digitalization, data platforms, and artificial intelligence to support research, development, and industrial applications. Betolar's solutions are designed to help reduce carbon emissions, decrease reliance on virgin raw materials, and improve the utilization of industrial byproducts. Its activities span construction materials, metal extraction technologies, and circular material solutions that support more resource-efficient industrial processes.
Show all investments...

ACME Investments
VC Fund · Luxembourg, Luxembourg, Luxembourg · 2 investments in Finland Biotechnology startups

ACME Investments is a venture capital company that invests in the software, healthcare, and pharmaceutical industries.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Apps
  • Stage:Series A, Venture - Series Unknown
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Aiforia — Aiforia provides software and services for pathologists, scientists and healthcare professionals to use artificial intelligence for image analysis.
  • TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Show all investments...

StartUp Health
VC Fund · New York, New York, United States · 2 investments in Finland Biotechnology startups

Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots

Show more...

Investment focus

  • Industry: Health Care, Wellness, Medical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 335
  • Round size: Seed $100k–$4M; Pre-Seed $20k–$854k
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2018

Portfolio highlights

  • AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
  • Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
  • NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Show all investments...

Sto-Rahoitus
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

Sto-Rahoitus

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Series A
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Round size: Series A $2M–$5.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Aiforia — Aiforia provides software and services for pathologists, scientists and healthcare professionals to use artificial intelligence for image analysis.
  • Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 2 investments in Finland Biotechnology startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 350
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
EQT Life Sciences
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Finland Biotechnology startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, The Netherlands, Switzerland

Investor stats

  • Total investments: 189
  • Round size: Series A $7.3M–$78M; Series B $11M–$114M; Series C $12M–$165M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $282M in 2023

Portfolio highlights

  • ActoGeniX — ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
  • Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
  • Rotation Medical — Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota.
Show all investments...

Lundbeckfonden Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 1 investments in Finland Biotechnology startups

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 72
  • Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $10M–$53M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
  • SNIPR Biome — We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
  • Women in Life Science Denmark — WiLD is a networking platform for women in senior positions in business and academia that is motivating and focused on science.
Show all investments...

K5 Global
VC Fund · Los Angeles, California, United States · 1 investments in Finland Biotechnology startups

Backing category-defining companies from inception to IPO.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Brazil

Investor stats

  • Total investments: 269
  • Round size: Seed $100k–$12M; Pre-Seed $50k–$5.5M; Series A $675k–$41M
  • Lead/follow: 2% lead, 98% follow
  • Last fund: Likely actively investing — fresh fund, raised $6M in 2025

Portfolio highlights

  • Atoms — Atoms is a robotics startup that develops industrial robotics and physical AI systems designed to automate tasks across mining, transport, and food-related operations. The company builds specialized, task-oriented machines rather than general-purpose robots, focusing on improving productivity in environments that involve physical labor andlogistics. Its technology centers on applying software-like principles to real-world systems, using robotics, sensors, and data-driven models to manage and execute industrial processes. The company structures its activities into distinct segments aligned with key industries, including food infrastructure, mining operations, and transportation systems. In the food sector, it develops automated infrastructure that supports preparation and production workflows, while in mining, it focuses on increasing operational efficiency through robotic systems designed for extraction and site activities. Its transport-related efforts include building a foundational robotic platform, described as a “wheelbase,” that supports mobility and deployment of machines in logistics and industrial settings.
  • Synchron — The endovascular brain computer interface.
  • Luxe Software — Building an operating system for jewelry stores. Vertical SaaS.
Show all investments...

Tiger Global Management
VC Fund · New York, New York, United States · 1 investments in Finland Biotechnology startups

Founded in 2001, Tiger Global Management, LLC (“Tiger Global”) is a New York-based investment firm pursuing a long-term approach to investing in leading, global public and private companies that leverage technological innovation. Tiger Global’s public equity business includes fundamentally oriented long/short, long-focused and crossoverstrategies, targeting investments in high-quality, public growth companies. The private equity business invests in early through late stage companies that pursue innovative approaches to new and existing industries, building on over 20 years of experience investing in hundreds of businesses in more than 30 countries with more than 90 portfolio company IPOs. With a strong track record investing across sectors and stages, Tiger Global aims to be a thought partner to companies and their management teams across their lifecycle in public and private markets. The Firm’s mission is to generate world-class returns for its investors and to do so in a way that makes its employees, partners and portfolio companies proud.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Series B, Series A, Series C
  • Geography: United States, India, China

Investor stats

  • Total investments: 1380
  • Round size: Series A $6.5M–$50M; Series B $19M–$128M; Series C $30M–$255M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Kavak — KAVAK is an innovative company in the automotive industry that helps people acquire their own car, offering a wide range of guaranteed and certified cars.
  • StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
  • OfBusiness — OFB Tech (OfBusiness) is a tech-enabled platform that facilitates raw material procurement and credit for SMEs with a focus on the manufacturing and infrastructure sectors. It integrates technology to SME's buying behavior to make available better products, at better prices, in better timelines to customers with comprehensive online andoffline support. Key raw materials include metals, chemicals, polymers, Agri commodities, petrochemicals, and building materials. OfBusiness provides SMEs access to cash flow-based financing for buying raw materials through its NBFC 'Oxyzo Financial Services'. The Company also offers a host of tech services for SMEs including BidAssist for new growth opportunities.
Show all investments...

CPT Capital
VC Fund · London, England, United Kingdom · 1 investments in Finland Biotechnology startups

Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 63
  • Round size: Seed $1.3M–$7M; Series A $6M–$50M; Series B $16M–$226M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
  • Xias Bio — Mitigate risk with flexible licensing options. Partner with us to transform your ideas into high-performance innovations optimized for efficacy and differentiation.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Show all investments...

Keksintösäätiö
VC Fund · 1 investments in Finland Biotechnology startups

Keksintösäätiö

Show more...

Investment focus

  • Industry: Apps, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Finland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Show all investments...

Horizon 2020
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Finland Biotechnology startups

The EU framework programme for research and innovation

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Grant, Seed, Venture - Series Unknown
  • Geography: Spain, United Kingdom, Switzerland

Investor stats

  • Total investments: 210
  • Round size: Seed $61k–$5.8M; Grant $56k–$3.9M; Venture - Series Unknown $1.9M–$9.2M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • 3Dock — 3Dock provides cloud-based 3D printing services for companies that need additional production capacity. The platform allows team collaboration by sharing designs, tracking progress, and managing projects in real time. Printing jobs can be started remotely, enabling work from the office or home. The service provides access to professional 3Dprinting infrastructure without requiring hardware investments. It also supports large-scale prototyping and product development for multiple departments within a company.
  • NovaMea — NovaMea is a cleantech startup that designs and commercializes electrochemical systems for energy storage and conversion.Its purpose is to create technology, services, and products for the storage and conversion of energy using electrochemical processes, as well as to produce, store, sell, and distribute these products and their components.
  • Perciv AI — Perciv provides artificial intelligence (AI)-based software solutions to unlock the latent possibilities of radars and allow resilient and economical autonomous systems with Lidar-like performance even in severe weather circumstances.
Show all investments...

Metsola Ventures
VC Fund · Espoo, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

Metsola Ventures

Show more...

Investment focus

  • Industry: Medical, mHealth, Automotive
  • Stage:Series A, Pre-Seed
  • Geography: Finland

Investor stats

  • Total investments: 3
  • Round size: Series A $2.2M–$5.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
  • RoadCloud — Use the worlds most accurate road condition data to your advantage. Real-time hyperlocal road weather data from your road network 24/7.
  • Synoste — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Show all investments...

Advent Life Sciences
VC Fund · London, England, United Kingdom · 1 investments in Finland Biotechnology startups

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 73
  • Round size: Series A $5.5M–$51M; Series B $21M–$97M; Venture - Series Unknown $7M–$104M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
  • Glycomine — We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Green Campus Innovations Oy
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

Provide an effective, outsourced incubation and acceleration platform .

Show more...

Investment focus

  • Industry: Energy, Manufacturing, Electric Vehicle
  • Stage:Pre-Seed, Venture - Series Unknown, Seed
  • Geography: Finland, Norway

Investor stats

  • Total investments: 6
  • Round size: Venture - Series Unknown $616k–$2.5M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • PikaPay — Our mission is to transform as many industries to self-service to have a better service experience for everyone.
  • Akkurate — Sandvik Battery Electric Loaders and Trucks TH550B LH518B Mobile Charging Station Battery as a Service
  • The Human Touch Robotics — Introducing robotics with the lightness of the human touch in realms once thought impossible.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
MTIP AG
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in Finland Biotechnology startups

MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!

Show more...

Investment focus

  • Industry: Health Care, Medical, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Spain

Investor stats

  • Total investments: 29
  • Round size: Series A $1.5M–$36M; Series B $10M–$30M; Series C $9.3M–$80M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: Likely still investing — raised $250M in 2021

Portfolio highlights

  • TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
  • Verifarma — Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals.
  • NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Show all investments...

Capricorn Partners
VC Fund · Leuven, Vlaams-Brabant, Belgium · 1 investments in Finland Biotechnology startups

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: Belgium, The Netherlands, United States

Investor stats

  • Total investments: 121
  • Round size: Series A $3.3M–$18M; Series B $5.3M–$45M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely actively investing — fresh fund, raised $53M in 2025

Portfolio highlights

  • Endo Tools Therapeutics — Endo Tools Therapeutics is dedicated to the development of innovative devices that provide therapeutic interventions for gastric conditions
  • Delft Advanced Biorenewables — We enable the bio-economy by improving the productivity of fermentations with our in-situ product recovery (ISPR) technology.
  • Trillium Renewable Chemicals — Trillium Renewable Chemicals manufactures chemicals from renewable feedstocks used in a variety of industrially important applications. The company was founded in 2021 and based in Knoxville, Tennessee.
Show all investments...

Bridford Investments
VC Fund · 1 investments in Finland Biotechnology startups

Bridford Investments

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Energy
  • Stage:Venture - Series Unknown, Series A, Series B
  • Geography: Sweden, Belgium, Finland

Investor stats

  • Total investments: 7
  • Round size: Venture - Series Unknown $6.1M–$2.8B
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Northvolt — Northvolt develops sustainable lithium-ion batteries in conjunction with R&D, industrialization, and recycling to support clean energy. It provides electrification and renewable energy storage designed for lithium-ion battery plant to produce batteries for electric vehicles. Northvolt's product is an environment-friendly batterymanufactured with minimal carbon footprint and with recycling technology without compromising with important eco-systems, enabling the auto industry to replace fossil fuels with electricity in an efficient manner. The company aims to establish a supply of sustainable battery cells and systems.In 2016, Paolo Cerruti and Peter Carlsson headquartered the company in Stockholm, Stockholms Lan.
  • Classified Cycling — Classified Cycling
  • Touchlight Genetics — Founded in 2008, Touchlight brings together a highly talented scientific and drug development team supported by an experienced board.Founder and CEO Jonny Ohlson has assembled a dynamic management team, including Clive Dix, Non Executive Chairman, and John Tite, Executive Head of Research (formerly founding CEO of Bicycle Therapeutics), withsubstantial experience in growing life science companies and particularly in DNA vaccines. Touchlight is supported by a group of Non-Executive Directors, who bring a wealth of healthcare and entrepreneurial experience.Led by experienced drug pharmaceutical scientists Neil Porter and Jill Makin, Touchlight’s scientific team- some of the brightest talents in the UK industry- has successfully established and patented the proTLx™ synthetic DNA platform as well as successfully establishing the first therapeutic proof-of-principle through collaboration with leading academic partners.The company has established strong collaborative links with academic laboratories worldwide including Imperial College London, Southampton University, Queen’s University Belfast and the University of Pennsylvania in the US.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in Finland Biotechnology startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 230
  • Round size: Series A $5.1M–$85M; Series B $11M–$120M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
  • Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
  • Rein Therapeutics — Rein Therapeutics is advancing a novel pipeline of first-in-class medicines to address unmet medical needs in orphan pulmonary and fibrosis indications.
Show all investments...

XR Invest
VC Fund · 1 investments in Finland Biotechnology startups

XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.

Show more...

Investment focus

  • Industry: Medical Device, Sensor, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Finland, United States

Investor stats

  • Total investments: 4
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
  • Synoste — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Show all investments...

Wave Ventures
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

Founded in 2016, Wave Ventures is the largest student-run VC in Europe, backed by Nordic unicorn founders, investing in Gen Z entrepreneurs at the earliest stage. We operate both from Finland and Sweden with a team of five people from the top universities in the region.

Show more...

Investment focus

  • Industry: Software, Mobile Apps, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Finland, Sweden, Germany

Investor stats

  • Total investments: 30
  • Lead/follow: no public data

Portfolio highlights

  • Bought — Everything you've bought, automatically ready for resale.
  • Sustashift — Sustashift offers a comprehensive legal CSRD reporting tool, providing tailored audit templates and automated XBRL tagging to streamline compliance and reduce manual reporting efforts.
  • Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Show all investments...

Zhejiang Huahai Pharmaceutical
VC Fund · Linhai, Zhejiang, China · 1 investments in Finland Biotechnology startups

Zhejiang Huahai Pharmaceutical Co. Ltd. is a Phermaceutical Company.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Therapeutics
  • Stage:Series A
  • Geography: China, Finland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
  • Yannuo Pharmaceutical — Yannuo Pharmaceutical is a high-tech enterprise focusing on the research and development of complex injections. It has three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres. Relying on the advanced drug delivery technology platform, the company adheres to the clinical needs-oriented and conductsresearch and development of small molecule drugs, nucleic acid drugs, peptides, and protein drugs. Deepen development and industrialization, focusing on the tumor, contrast agents, anesthesia and pain, and other therapeutic areas.
Show all investments...

Nordea
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

Nordea Bank is Denmark's second-largest bank and counts every fourth Dane among its customers. Through their nationwide network of some 340 branch offices and a broad range of self-service facilities, they are able to offer you a full scale of financial products and services, including Netbank, Online Investment, telephone banking and cashdispensers.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Banking
  • Stage:Debt Financing, Seed
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 23
  • Lead/follow: no public data

Portfolio highlights

  • Tibber — Tibber is a digital electricity supplier that offers smart solutions to minimize their customers’ consumption and costs. Its vision is to make sustainable energy consumption simple and affordable for all households. Tibber's mission is to reduce the residential electricity consumption for European households by 20 %. Founded in Norway andSweden in 2016, the company has expanded its offer to Sweden and Germany where it powers hundreds of thousands of homes. Tibber replaces traditional utilities with smart technology, supplying its customers with renewable energy at fair and transparent prices. In addition, its app provides real-time analytics into energy usage, and pairs with a variety of smart home devices to reduce electricity consumption at home. The company sells tech-gadgets in their online store and recently was licensed to balance the main power grid in Sweden with EVs.
  • Statzon — Make data-driven plans & faster decisions with a simple access to +1M datasets & market reports about 8,000 topics from +200 trusted data providers.
  • Get It Done Now — GIDN is a Nigerian Fintech Company targeting medium and low income population for Loans and Financial products. GIDN has in addition a cashless, mobile based community marketplace, with more than 5k members, and aims to regulate the informal economy and facilitate the purchase of Services and Digital Products.
Show all investments...

University of Helsinki
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The Universityconcentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.

Show more...

Investment focus

  • Industry: Apps, Hospital, Consulting
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Finland, Luxembourg

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • NADMED — The standard of NAD measuring
  • Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Show all investments...

Valio
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

We are Valio Group: the most innovative dairy and food company in the world.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Series A, Series B
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
Show all investments...

Biotechnology VC funding in Finland at a glance

Stats across 187 deals from 157 investors.

157
investors
in Finland Biotechnology startups
187
deals
in Finland Biotechnology startups
$3.1M
median round
in Finland Biotechnology startups
46%
lead investors
lead at least one round
26%
Grant
most common funding stage

Access all 157 VC funds in Finland Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 157 VC funds investing in Finland Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists